Hot Features
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-06-01 | Mr. Christopher W. DonagheyPresident, CEO, & Director | -10,00k | 15,00k | Vente | 1,50 | 113,59k | -8,09% |
| 2026-05-11 | Mr. Bradford Thomas AdamczykExecutive Chairman of Board | -10,00k | 14,30k | Derivative Exercise and Sale | 0,07 - 1,50 | 2,24M | - |
| 2026-05-11 | Mr. Christopher W. DonagheyPresident, CEO, & Director | -10,00k | 15,00k | Vente | 1,50 | 123,59k | -7,49% |
| 2026-01-26 | Mr. Christopher W. DonagheyPresident, CEO, & Director | -10,00k | 16,50k | Vente | 1,65 | 133,59k | -6,96% |
| 2026-01-21 | Dr. Gregory J. QuarlesCEO Emeritus, Government and Institutional Relations Executive & Director | -6,60k | 10,03k | Derivative Exercise and Sale | 0,35 - 1,87 | 0,00 | - |
| 2026-01-20 | Dr. Stephen William McCahonChief Scientist Officer | -10,00k | 18,00k | Vente | 1,80 | 12,77M | -0,08% |
| 2026-01-07 | Mr. Bradford Thomas AdamczykExecutive Chairman of Board | -10,00k | 17,00k | Derivative Exercise and Sale | 0,07 - 1,77 | 2,24M | - |
| 2025-12-26 | Mr. Christopher W. DonagheyPresident, CEO, & Director | -10,00k | 19,28k | Vente | 1,92 - 1,93 | 143,59k | -6,51% |
| 2025-12-22 | Dr. Stephen William McCahonChief Scientist Officer | -10,00k | 18,60k | Vente | 1,86 | 12,78M | -0,08% |
| 2025-12-22 | Dr. Gregory J. QuarlesCEO Emeritus, Government and Institutional Relations Executive & Director | -10,00k | 15,30k | Derivative Exercise and Sale | 0,35 - 1,88 | 0,00 | - |
| 2025-12-08 | Mr. Bradford Thomas AdamczykExecutive Chairman of Board | -10,00k | 17,90k | Derivative Exercise and Sale | 0,07 - 1,86 | 2,24M | - |
| 2025-12-04 | Dr. Gregory J. QuarlesCEO Emeritus, Government and Institutional Relations Executive & Director | -10,00k | 14,20k | Derivative Exercise and Sale | 0,35 - 1,77 | 0,00 | - |
| 2025-11-28 | Mr. Christopher W. DonagheyPresident, CEO, & Director | -10,00k | 15,00k | Vente | 1,50 | 153,59k | -6,11% |
| 2025-11-19 | Dr. Stephen William McCahonChief Scientist Officer | -10,00k | 15,09k | Vente | 1,50 - 1,51 | 12,79M | -0,08% |
| 2025-11-17 | Mr. Bradford Thomas AdamczykExecutive Chairman of Board | -10,00k | 15,10k | Derivative Exercise and Sale | 0,07 - 1,58 | 2,24M | - |
| 2025-10-27 | Mr. Christopher W. DonagheyPresident, CEO, & Director | -10,00k | 16,80k | Vente | 1,68 | 163,59k | -5,76% |
| 2025-10-20 | Dr. Stephen William McCahonChief Scientist Officer | -10,00k | 16,50k | Vente | 1,65 | 12,80M | -0,08% |
| 2025-09-25 | Mr. Christopher W. DonagheyPresident, CEO, & Director | -10,00k | 20,00k | Vente | 2,00 | 173,59k | -5,45% |
| 2025-09-24 | Dr. Gregory J. QuarlesCEO Emeritus, Government and Institutional Relations Executive & Director | -10,00k | 15,70k | Derivative Exercise and Sale | 0,35 - 1,92 | 0,00 | - |
| 2025-09-19 | Dr. Stephen William McCahonChief Scientist Officer | -10,00k | 15,00k | Vente | 1,50 | 12,81M | -0,08% |
| 2025-09-19 | Mr. Bradford Thomas AdamczykExecutive Chairman of Board | -10,00k | 14,30k | Derivative Exercise and Sale | 0,07 - 1,50 | 2,24M | - |
| 2025-08-15 | Mr. Bradford Thomas AdamczykExecutive Chairman of Board | -10,00k | 16,90k | Derivative Exercise and Sale | 0,07 - 1,76 | 2,24M | - |
| 2025-08-05 | Mr. Christopher W. DonagheyPresident, CEO, & Director | -10,00k | 19,80k | Vente | 1,98 | 183,59k | -5,17% |
| 2025-07-21 | Dr. Gregory J. QuarlesCEO Emeritus, Government and Institutional Relations Executive & Director | -10,00k | 19,00k | Derivative Exercise and Sale | 0,35 - 2,25 | 0,00 | - |
| 2025-07-15 | Mr. Bradford Thomas AdamczykExecutive Chairman of Board | -10,00k | 22,60k | Derivative Exercise and Sale | 0,07 - 2,33 | 2,24M | - |
| 2025-07-13 | Mr. Christopher W. DonagheyPresident, CEO, & Director | 62,57k | 0,00 | Derivative Exercise and Retained Stock | - | 193,59k | 47,75% |
| 2025-07-13 | Mr. Christopher W. DonagheyPresident, CEO, & Director | -37,44k | 84,98k | Derivative Exercise and Sale | 2,27 | 193,59k | - |
| 2025-07-07 | Mr. Christopher W. DonagheyPresident, CEO, & Director | -10,00k | 22,28k | Vente | 2,22 - 2,23 | 131,03k | -7,09% |
| 2025-06-23 | Dr. Gregory J. QuarlesCEO Emeritus, Government and Institutional Relations Executive & Director | -10,00k | 18,10k | Derivative Exercise and Sale | 0,35 - 2,16 | 0,00 | - |
| 2025-06-12 | Mr. Bradford Thomas AdamczykExecutive Chairman of Board | -10,00k | 18,00k | Derivative Exercise and Sale | 0,07 - 1,87 | 2,24M | - |
| 2025-06-05 | Mr. Christopher W. DonagheyPresident, CEO, & Director | -10,00k | 23,30k | Vente | 2,33 | 141,03k | -6,62% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.